高级检索
当前位置: 首页 > 详情页

Recommended prophylactic and management strategies for severe acute respiratory syndrome coronavirus 2 infection in transplant recipients.

文献详情

资源类型:
Pubmed体系:

收录情况: ◇ 统计源期刊 ◇ CSCD-C ◇ 中华系列

单位: [a]State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou MedicalUniversity, Guangzhou, Guangdong 510120, China [b]Department of Kidney Transplantation, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China [c]Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China [d]Department of Cardiovascular Surgery, Affiliated Union Hospital, Huazhong University of Science and Technology, Wuhan, Hubei 430022,China [e]Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing 100083, China [f]Department of Kidney Transplantation,Affiliated Tongji Hospital,Huazhong University of Science and Technology,Wuhan,Hubei 430071,China [g]Department of Kidney Transplantation, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China [h]Department of Hematology, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China
出处:
ISSN:

关键词: Novel coronavirus Corona virus disease 2019 Transplantation Pneumonia Recipients

摘要:
Since December 2019, increasing attention has been paid to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in Wuhan, China. SARS-CoV-2 primarily invades the respiratory tract and lungs, leading to pneumonia and other systemic disorders. The effect of SARS-CoV-2 in transplant recipients has raised significant concerns, especially because there is a large population of transplant recipients in China. Based on the current epidemic situation, this study reviewed publications on this virus and coronavirus disease 2019 (COVID-19), analyzed common features of respiratory viral pneumonias, and presented the currently reported clinical characteristics of COVID-19 in transplant recipients to improve strategies regarding the diagnosis and treatment of COVID-19 in this special population.

基金:
语种:
PubmedID:
第一作者:
第一作者单位: [a]State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou MedicalUniversity, Guangzhou, Guangdong 510120, China
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:408 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)